Summary
In vivo voltammetry was used in freely moving rats to study the processes whereby striatal dopamine (DA) release is regulated by corticostriatal glutamatergic neurons. Electrical stimulation of the cerebral cortex was found to markedly increase the striatal DA-related voltammetric signal amplitude. Similar enhancements have been observed after intracerebroventricular administration of 10nmoles glutamate, quisqualate and AMPA, whereas NMDA was found to decrease the amplitude of the striatal signals. The NMDA receptor antagonist APV did not significantly affect the voltammetric signal but prevented the NMDA-induced depression of the DA-related signals. These data are in agreement with those obtained in numerous previous studies suggesting that the glutamatergic corticostriatal neurons exert activatory effects on the striatal DA release via non-NMDA receptors. The mechanism involved might be of a presynaptic nature. The role of the NMDA receptors may however consist of modulating the dopaminergic transmission phasically and in a depressive way, which would be consistent with behavioural data suggesting the existence of a functional antagonism between the activity of the corticostriatal glutamatergic and nigrostriatal dopaminergic systems.
Similar content being viewed by others
Abbreviations
- Glu:
-
glutamate
- DA:
-
dopamine
- NMDA:
-
N-methyl-D-aspartate
- CPP:
-
3-(2-carboxypiperazin-4µl)propyl-1-phosphonic acid
- AMPA:
-
α-amino-3-hydroxy-5-metylisoxazole-4-propionic acid
- APV:
-
aminophosphonovaleric acid
- DOPAC:
-
dihydroxyphenylacetic acid
- HVA:
-
homovanillic acid
- DARPP 32:
-
dopamine-cAMP-regulated phosphoprotein 32
- CSF:
-
cerebrospinal fluid
References
Barbeito L, Chéramy A, Godeheu G, Desce JM, Glowinski J (1990) Eur J Neurosci 2: 304–311
Butcher SP, Liptrot J, Arbuthnott GW (1991) Neurosci Lett 122: 245–248
Carlsson M, Carlsson A (1990) TINS 13: 272–276
Carter CJ, Pycock CJ (1980) Brain Res 192: 163–176
Carter CJ, L'Heureux R, Scatton B (1988) J Neurochem 51: 462–468
Chéramy A, Romo R, Godeheu G, Baruch P, Glowinski J (1986) Neuroscience 19: 1081–1090
Clow DW, Jhamandas K (1988) J Pharmacol Exp Ther 248: 722–728
Dusticier N, Nieoullon A (1987) Neurochem Int 10: 275–280
El Ganouni S, Forni C, Nieoullon A (1987) Brain Res 404: 239–256
Elliott PJ, Close SP, Walsh DM, Hayes AG, Marriott AS (1990) J Neural Transm 2: 91–100
Errami M, Nieoullon A (1988) J Neurochem 51: 579–586
Forni C, Nieoullon A (1984) Brain Res 297: 11–20
Forni C, Brundin P, Strecker RE, El Ganouni S, Bjorklund A, Nieoullon A (1989) Exp Brain Res 76: 75–87
Fuxe K, Agnati LF (1991) Volume transmission in the brain. Novel mechanisms for neural transmission. Adv Neuroscience 1: 1–624
Giorguieff MF, Kemel ML, Glowinski J (1977) Neurosci Lett 6: 73–77
Girault JA, Halpain S, Greengard P (1990) TINS 13: 325–326
Glick SD (1972) Europ J Pharmacol 20: 351–355
Hassler R, Hang P, Nitsch C, Kim JS, Paik K (1982) J Neurochem 38: 1087–1098
Herrera-Marschitz M, Goiny M, Utsumi H, Ferre S, Guix T, Ungerstedt U (1990) In: Lubec G, Rosenthal GA (eds) Amino acids, chemistry, biology and medicine. ESCOM Science, Leiden, pp 599–604
Herrera-Marschitz M (1991) In: Bernardi G, Carpenter MB, Di Chiara G, Morelli M, Stanzione P (eds) The basal ganglia III. Plenum Press, New York, pp 357–362
Imperato A, Honoré T, Jensen LH (1990) Brain Res 530: 223–228
Jhamandas K, Marien M (1987) Br J Pharmacol 90: 641–650
Jones MW, Kilpatrick IC, Phillipson OT (1988) Brain Res 475: 8–20
Kabuto H, Yokoi I, Mizukawa K, Mori A (1989) Neurochem Res 14: 1075–1080
Kashihara K, Hamamura T, Okumura K, Otsuki S (1990) Brain Res 528: 80–82
Konig JFR, Klippel RA (1963) The rat brain. A stereotaxic atlas of the forebrain and lower part of the brain stem. Williams and Wilkins, Baltimore
Krebs MO, Desce JM, Kemel ML, Gauchy C, Godeheu G, Chéramy A, Glowinski J (1991a) J Neurochem 56: 81–85
Krebs MO, Kemel ML, Gauchy C, Desban M, Glowinski J (1989) Europ J Pharmacol 166: 567–570
Krebs MO, Trovero F, Desban M, Gauchy C, Glowinski J, Kemel ML (1991b) J Neurosci 11: 1256–1262
Leviel V, Gobert A, Guibert B (1990) Neurosci 39: 305–312
Mehta AK, Ticku MK (1990) Life 46: 37–42
Moghaddam B, Gruen RJ (1991) Brain Res 544: 329–330
Moghaddam B, Gruen RJ, Roth RH, Bunney BS, Adams RN (1990) Brain Res 518: 55–60
Nieoullon A, Chéramy A, Glowinski J (1978) Brain Res 145: 69–83
Nieoullon A, Kerkerian L, Dusticier N (1983) Exp Brain Res [Suppl]7: 54–65
Rao TS, Cler JA, Mick SJ, Emmet MR, Farah JM, Contreras PC, Iyengar S, Wood PL (1991) J Neurochem 56: 907–913
Roberts PJ, Sharif NA (1978) Brain Res 157: 391–395
Roberts PJ, Mc Bean GJ, Sharif NA, Thomas EM (1982) Brain Res 235: 83–91
Samuel D., Errami M, Nieoullon A (1990) J Neurochem 54: 1926–1933
Scatton B, Worms P, Lloyd KG, Bartholini G (1982) Brain Res 232: 331–343
Shimizu N, Duan S, Hori T, Oomura Y (1990) Brain Res Bull 25: 99–102
Snell LD, Johnson KM (1986) J Pharmacol Exp Ther 238: 938–946
Wang JKT (1991) J Neurochem 57: 819–822
Weihmuller FB, O'Dell SJ, Cole BN, Marshall JF (1991) Brain Res 549: 230–235
Westerink BHC (1985) Neurochem Int 7: 221–227
Worms P, Willigens MT, Continsouza-Blanc D, Lloyd KG (1985) Europ J Pharmacol 113: 53–59
Zetterström T, Sharp T, Collin AK, Ungerstedt U (1988) Europ J Pharmacol 148: 327–334
Author information
Authors and Affiliations
Additional information
Laboratory associated with the University of Aix-Marseille II
Rights and permissions
About this article
Cite this article
Forni, C., Dusticier, N. & Nieoullon, A. Further contribution to the study of corticostriatal glutamatergic and nigrostriatal dopaminergic interactions within the striatal network: an in vivo voltammetric investigation. Amino Acids 3, 53–68 (1992). https://doi.org/10.1007/BF00806008
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00806008